Rocket Pharmaceuticals Inc reports results for the quarter ended in January 1 - Earnings Summary

Rocket Pharmaceuticals

08/11/2024 05:02

* Rocket Pharmaceuticals Inc  RCKT.OQ  reported a quarterly
adjusted loss of 71 cents​​ per share for the quarter ended
January 1, higher than the same quarter last year, when the
company reported EPS of -75 cents.  The mean expectation of
fifteen analysts for the quarter was for a loss of 76 cents per
share. Wall Street expected results to range from -84 cents
to -65 cents per share.
    * Reported revenue was zero​; analysts expected $705.00
thousand. 
    * Rocket Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 71 cents​.
    * The company reported a quarterly loss of $66.72 million.
    * Rocket Pharmaceuticals Inc shares had fallen by 4.8% this
quarter and lost 41.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 15 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rocket
Pharmaceuticals Inc is $48.00 
This summary was machine generated from LSEG data November 8 at
05:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.76          -0.71          Beat
 Jun. 30 2024      -0.72          -0.74          Missed
 Mar. 31 2024      -0.68          -0.66          Beat
 Dec. 31 2023      -0.79          -0.64          Beat